Differential impact of the pandemic first wave on chronic respiratory diseases in France
Authors:
Preprint
- 28 October 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background. The COVID-19 pandemic has been associated with dramatic changes in the management of patients with chronic respiratory diseases (CRD), resulting in varying clinical profile and use of healthcare services of patients hospitalised. Patients and Methods. Using the French national hospital database, we analysed changes in epidemiological profile, clinical presentation at hospital referral and outcomes (ICU admission and in-hospital mortality) of CRD patients hospitalised for COVID-19 during the first wave of the pandemic in France. Results. Non-interstitial CRD and pulmonary vascular diseases (PVD) were the most prevalent CRDs (95%). The part of CRD patients among the total inpatients was substantial, decreasing during lockdown (from 12.1% to 10.8%), then returning to the pre-lockdown level (12.4%). The CRD patients were older and comorbid males with higher rates of ICU admission and mortality, as compared with their counterparts. Half of them had a complicated clinical profile (CCP, ICU admission or death). Overall, in-hospital length of stay was 9 (4-16) days and mortality rate 19.8%. These characteristics varied along time. In multivariable analyses, PVD was associated with a CCP (aORs, from 1.36; CI 1.18-1.57 to 1.82; CI 1.56-2.12) and mortality (with aHRs >1.5 in the 18-55 and 56-75 age groups). Conclusion. We report a substantial part of CRD patients hospitalised with COVID-19, characterized by a more severe initial clinical presentation and higher rates of complicated stays, with changes along time suggesting differential exposure and use of resources. The PVD subgroup was independently associated with CCP and mortality during the entire study period.Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Effects of COVID-19 pandemic on the management of pulmonary hypertensionRespiratory Medicine, 2022
- Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral InfectionsThe American Journal of Medicine, 2021
- Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million peopleThe Lancet Regional Health - Europe, 2021
- Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 InfectionJAMA Oncology, 2021
- Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2Journal of Allergy and Clinical Immunology, 2020
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyThe Lancet, 2020
- Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesThe Lancet Infectious Diseases, 2020
- Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cellsRespiratory Investigation, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in FranceRevue D'Épidémiologie Et de Santé Publique, 2017